This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2002 Nov 14;420(6912):116-8.

doi: 10.1038/420116a.

A tragic setback

PMID: 12432357
DOI: 10.1038/420116a

A tragic setback

Erika Check. Nature. 2002.

. 2002 Nov 14;420(6912):116-8.

doi: 10.1038/420116a.

Author

PMID: 12432357
DOI: 10.1038/420116a

No abstract available

PubMed Disclaimer

Similar articles

The trials of gene therapy.
[No authors listed] [No authors listed] Nature. 2002 Nov 14;420(6912):107. doi: 10.1038/420107a. Nature. 2002. PMID: 12432344 No abstract available.
Second cancer case halts gene-therapy trials.
Check E. Check E. Nature. 2003 Jan 23;421(6921):305. doi: 10.1038/421305a. Nature. 2003. PMID: 12540867 No abstract available.
Clinical research. Gene therapy a suspect in leukemia-like disease.
Marshall E. Marshall E. Science. 2002 Oct 4;298(5591):34-5. doi: 10.1126/science.298.5591.34. Science. 2002. PMID: 12364755 No abstract available.
Occurrence of leukaemia following gene therapy of X-linked SCID.
Kohn DB, Sadelain M, Glorioso JC. Kohn DB, et al. Nat Rev Cancer. 2003 Jul;3(7):477-88. doi: 10.1038/nrc1122. Nat Rev Cancer. 2003. PMID: 12835668 Review.
Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
McCormack MP, Rabbitts TH. McCormack MP, et al. N Engl J Med. 2004 Feb 26;350(9):913-22. doi: 10.1056/NEJMra032207. N Engl J Med. 2004. PMID: 14985489 Review. No abstract available.

See all similar articles

Cited by

Nanomedicine for gene therapy.
Alex SM, Sharma CP. Alex SM, et al. Drug Deliv Transl Res. 2013 Oct;3(5):437-45. doi: 10.1007/s13346-012-0120-0. Drug Deliv Transl Res. 2013. PMID: 25788352
Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors.
Bii VM, Trobridge GD. Bii VM, et al. Cancers (Basel). 2016 Oct 25;8(11):99. doi: 10.3390/cancers8110099. Cancers (Basel). 2016. PMID: 27792127 Free PMC article. Review.
An Alternate Approach to Generate Induced Pluripotent Stem Cells with Precise CRISPR/Cas9 Tool.
Javaid N, Choi S. Javaid N, et al. Stem Cells Int. 2022 Sep 22;2022:4537335. doi: 10.1155/2022/4537335. eCollection 2022. Stem Cells Int. 2022. PMID: 36187228 Free PMC article.
Ethical perspectives on RNA interference therapeutics.
Ebbesen M, Jensen TG, Andersen S, Pedersen FS. Ebbesen M, et al. Int J Med Sci. 2008 Jun 25;5(3):159-68. doi: 10.7150/ijms.5.159. Int J Med Sci. 2008. PMID: 18612370 Free PMC article.
Manipulating piggyBac transposon chromosomal integration site selection in human cells.
Kettlun C, Galvan DL, George AL Jr, Kaja A, Wilson MH. Kettlun C, et al. Mol Ther. 2011 Sep;19(9):1636-44. doi: 10.1038/mt.2011.129. Epub 2011 Jul 5. Mol Ther. 2011. PMID: 21730970 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information